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Abstract
Background Increasing numbers of older people are
receiving support with medicines management from com-
munity nursing services (CNSs) to enable them to live in
their own homes. Little is known about these people and
the support they receive.
Objectives To explore the characteristics of older people
referred for medicines management support, type of sup-
port provided, medication errors and adverse medication
events (AMEs).
Methods A retrospective observational study of a random
sample of 100 older people referred to a large non-profit
CNS for medicines management support over a 3-month
period was conducted. Measures were: demographics,
referral source, current medical problems, medicines,
medication aids, types of medication authorisations used by
nurses, frequency of nurse visits and type of support pro-
vided, medication errors, AMEs and interdisciplinary
teamwork among community nurses, general practitioners
and pharmacists.
Results Older people (median 80 years) were referred
for medicines support most often by hospitals (39 %).
Other referrals were from families/carers, case-managers,
palliative care services and general practitioners. Multiple
health conditions (median 5) and medicines (median 10)
were common; 66 % used C5 medicines; 48 % used C1
high-risk medicines—most commonly opiates, anticoag-
ulants and insulin. Medication aids were frequently used,
mostly multi-compartment dose administration aids
(47 %). Most people received regular community nurse
visits (C4 per week) to administer medicines or monitor
medicine-taking. Only 16 % had a medication adminis-
tration chart; for other clients nurses used medicine lists
or letters from doctors for medication authorisation.
Medication errors occurred in 41 % of people and 13 %
had C1 AME requiring medical consultation or hospital-
isation; 9/13 (64 %) AMEs were potentially preventable.
There was little evidence of interdisciplinary teamwork or
medication review.
Conclusion CNS clients had multiple risk-factors for
medication misadventure. Deficiencies in medicines man-
agement were identified, including low use of medication
charts and interdisciplinary medication review. Strategies
are needed to improve medicines management in the home-
care setting.
Electronic supplementary material The online version of this
article (doi:10.1007/s40801-016-0065-6) contains supplementary
material, which is available to authorized users.
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Key Points
Older people referred to a community nursing
service (CNS) for support with medicines
management received intensive assistance, often
over a prolonged period; they had multiple risk-
factors for adverse medication events but
interdisciplinary collaboration and medication
review was uncommon.
Medication errors and adverse medication events
requiring medical consultation occurred in 41 and
13 % of CNS clients respectively; a majority of
adverse medication events were preventable.
There is a need to develop and test strategies to
improve medication safety for CNS clients.
1 Introduction
The number of older Australians has increased by 65 %
over the last 20 years [1]. Over the same period there has
been a growing focus on supporting older people to remain
living in their own homes for as long as possible [2], and an
increase in the intensity of treatment for medical conditions
that commonly affect older people (such as cardiovascular
disease, diabetes, osteoporosis), leading to increased
polypharmacy and medication regimen complexity [3].
Together these factors have led to increased demand for
community nursing services (CNSs) to support older peo-
ple with managing medicines at home [4]. A large Aus-
tralian CNS recently reported that 56 % of its home
nursing visits were primarily for the purpose of supporting
medicines management [5]. Similar trends have been
reported internationally [6].
There is evidence that older people receiving home
nursing care are a group at high risk of medication-related
problems and adverse medication events (AMEs) [7–10]. It
has been suggested that the risk of medication-related
problems among CNS clients may be greater than in other
healthcare settings such as hospitals and residential aged-
care facilities because of the unstructured environment and
communication challenges in the home care setting [11].
For example, home care nurses have a less direct rela-
tionship and less contact with clients’ medical practitioners
and pharmacies. There may be multiple prescribers and
multiple pharmacies involved in the client’s care. Pre-
scribers and pharmacists may not see the client regularly
and may rely on the nurse to report medication-related
problems. Home-care clients and their informal carers
often participate in their own medicines management (by
self-administering some medicines, attending medical
appointments, purchasing over-the-counter medicines, etc.)
which means there is potential for non-adherence and
medication self-administration errors [11, 12].
Despite large numbers of people receiving CNS support,
there has been little research focusing on this group [12,
13]. In Australia, Johnson et al. used a convenience sample
of 111 CNS clients to develop medication risk assessment
criteria and test a nurse-led intervention to improve med-
icine use [7, 14], and While et al. [15–17] conducted a
series of qualitative studies exploring issues related to
medicines management in CNS clients and their carers.
Whilst these studies, and similar studies from other coun-
tries [9, 10, 12], highlighted complexities and problems
related to medicines management, they did not recruit
representative samples of CNS clients or report the fre-
quency or type of medicines management support provided
or the prevalence of medication errors and AMEs. Know-
ing more about people who receive medicines management
support from CNSs, the types of support they receive and
medication-related problems and AMEs encountered, may
help with identifying areas for improvement and planning
future care needs for home-care clients.
The aim of this study was to describe the characteristics
of community-dwelling older people referred to an Aus-
tralian CNS for support with medicines management, their




The study was conducted at two metropolitan sites of a
large, not-for profit CNS in Melbourne, Australia. The sites
employed 120 registered nurses (degree-qualified nurses),
nine enrolled nurses (diploma- or certificate-qualified nur-
ses) and eight community care aides (non-nurse profes-
sional care workers).
2.2 Subjects
One hundred CNS clients were randomly selected (using a
random number generator) from all people aged 50 years
and over who were referred for medicines support between
16 July and 12 October 2012.
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2.3 Data Collection
Data were collected (May–December 2013) by retrospec-
tive review of clients’ CNS records and telephone contact
with clients’ general practitioners (GPs) and pharmacies,
using a pre-piloted data collection form. Data collected,
and definitions, are provided in Table 1.
Referral details, medical problems, cognitive function
and use of medication aids were obtained from referral
documents, CNS admission notes and care plans. Medici-
nes used by clients were obtained from medication
authorisations.
CNS home visits, medication errors, AMEs and dis-
charge location were identified by reviewing CNS progress
notes and discharge records. Evidence of interdisciplinary
teamwork was identified from CNS records and telephone
calls to clients’ GPs and/or community pharmacies.
2.4 Data Analysis
Age-adjusted Charlson Co-morbidity Index scores were
calculated (a score of C 5 indicates at high risk of mor-
tality) [18]. The use of medicines associated with height-
ened risk of adverse events was determined by a
pharmacist researcher, who compared clients’ medicine
lists against a pre-defined list of ‘risk’ medicines (Table 1).
Potential AMEs were reviewed by an expert panel to
determine causality, preventability and contribution to
hospital admission, using modified Hallas criteria [19, 20].
The panel comprised three clinical pharmacists and two
registered nurses, each with over 15 years of experience
encompassing hospital and community aged care. Panel
members assessed each case independently. When there
was disagreement, the case was discussed until consensus
was reached. Severity was assessed using Pearson criteria
Table 1 Data collected and definitions
Data (definition)
Source of referral to the CNS
Reason for referral to the CNS
Current medical problems (active medical problems at the time of admission to the CNS)
Presence of cognitive impairment (documented dementia or mild cognitive impairment, Mini-Mental State Examination score\24 or
Rowland Universal Dementia Assessment Scale score\23)
Medicines used at the time of CNS admission (medicines listed on the clients’ first ‘medication authorisation’)
Use of medicines associated with heightened risk of an adverse medication event if taken or administered incorrectly (high risk:
anticoagulants, chemotherapeutic agents excluding hormonal agents, immunosuppressant agents, insulins, lithium, opioids; moderate risk:
antibiotics, anticonvulsants, antipsychotics, benzodiazepines, loop diuretics, oral corticosteroids, oral hypogylcaemics) [42]
Medication management aids used (e.g. dose administration/adherence aids)
CNS visits in the first and last weeks of the CNS admissiona
Types of medication authorisations (medication administration charts or other medicine lists or instructions signed by a medical practitioner
authorising the CNS to administer medicines or support clients’ medicine self-administration) used during first and last weeks of admissiona
Medication errors (deviations from the prescriber’s instructions, whether or not they led to harm)
Adverse medication events (adverse drug reactions [ADRs] requiring medical consultation and unplanned medication-related hospital
admissions)
Evidence of interdisciplinary teamwork (documented communication between CNS staff and prescribers or pharmacists, Home Medicines
Reviews,b Team Care Arrangements,c Case Conferencesd)
Duration of CNS care (number of days from CNS admission to CNS discharge)e
Discharge location
CNS community nursing service
a For clients who had not been discharged from the CNS at the time of the audit, the last week of admission for the purpose of data collection
was taken to be the last week of available data (at least six months after admission to the CNS)
b Home Medicines Review (HMR) is an Australian Government funded program that is available to patients in the community setting who are at
risk of adverse medication events. A general practitioner can initiate an HMR by making a referral to an accredited consultant pharmacist
c Team Care Arrangement is an Australian Government funded (Medicare) service in which a general practitioner works with other health
professionals involved in a patient’s management to prepare and implement a multidisciplinary care plan
d Case conference is an Australian Government funded (Medicare) service in which a general practitioner organises, coordinates or participates
in a meeting or discussion held to ensure that their patient’s multidisciplinary care needs are met through a planned and coordinated approach
e CNS episodes of care that were temporarily interrupted by a period of residential respite or an acute hospitalisation were counted as one
episode of care
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[21], and the primary underlying cause of the AME was
classified using Hepler and Strand’s classification [22]. The
AME assessment criteria are provided in Supplementary
File 1.
Data were analysed using SPSS (version 21, IBM Cor-
poration, USA). Analyses were carried out using descrip-
tive tests, with results reported as frequency and proportion
for categorical variables and median and interquartile range
(IQR) for discrete and non-normally distributed continuous
variables.
3 Results
One hundred and ninety-seven people aged 50 years or
over were referred for medicines support. The character-
istics of the 100 clients selected for the study, and their
reasons for referral, are summarised in Table 2. CNS cli-
ents were visited a median of four to five days a week. In
the first week of care the most common reason for
medicines support visits was to administer medicines; in
the last week it was to monitor medicine-taking (Table 3).
A minority of clients (n = 16) had a medication ad-
ministration chart during the first week of their CNS
admission; 14 of these were handwritten by a hospital
doctor and two were printed or handwritten by a GP. The
remaining 84 clients’ treatment authorisations were printed
or handwritten medicine lists provided by the client’s GP
(n = 48), hospital doctor (n = 27), specialist (n = 1) or
unknown source (n = 8). Use of medication administration
charts remained low, with only 15 clients having one at the
time of discharge. Twenty-two clients had more than one
medication authorisation used concurrently (e.g. a GP
medicine list plus a letter from a GP or specialist indicating
a medicine change) during either the first or last week of
their CNS admission.
Medication authorisations for 85 clients included all of
their medicines. The other 15 clients’ authorisations
included a partial list only (usually parenteral medicines,
because the CNS was involved in administering those
medicines only). The 85 clients with a complete medicine
list used a median of ten medicines (IQR 6–13, range
2–26), and 66 % used five or more. The median number of
regular, long-term medicines (excluding ‘when required’
and short-term medicines) was eight (IQR 4–11, range
1–21). Forty-eight clients used one or more high risk
medicines, most commonly opiates (28 % clients), anti-
coagulants (17 % clients) and insulins (14 % clients).
One hundred and thirty-seven medication errors were
identified, affecting 41 (41 %) clients (Table 4). Twenty-
three (23 %) clients had an unplanned hospital admis-
sion—after expert panel review 9/23 (39.1 %) of these
were deemed to have been possibly medication-related
(Table 5). Five clients had an ADR that required medical
consultation without hospital admission. One client had
both a medication-related hospital admission and an ADR
without admission, so overall there were 13 (13 %) clients
with one or more AME requiring medical consultation or
hospitalisation (Table 5). Nine (64 %) AMEs were con-
sidered to have been potentially preventable. Eight clients
died at home; all were receiving end-of-life care for a
terminal illness prior to their death.
There was little evidence of interdisciplinary teamwork.
CNS nurses recorded contact with the clients’ GP or
pharmacy for only eight clients in the first week of care and
one in the final week. No client had a multidisciplinary
case conference documented at any time during their CNS
admission, and only one client had a Team Care
Arrangement. One client had a Home Medicines Review
(HMR) recorded in their CNS record; a further four had
received an HMR according to their GP or community
pharmacist.
4 Discussion
Community nursing services play a vital role in helping
frail older people to remain living in their own homes. This
is the first study to quantify and describe medicines man-
agement support and medication-related problems in a
representative sample of older people referred to a CNS. It
found that CNS clients had a very high prevalence of risk-
factors for medication-related problems, including multiple
co-morbidities, cognitive impairment, polypharmacy and
use of medicines associated with heightened risk. CNS
clients used a median of ten medicines, which is higher
than the average for community-dwelling older people
[23].
In the first week of care most clients were visited on at
least 5 days, mainly to administer medicines. In the last
week of care, the number of visits was slightly lower and
the most common form of support was monitoring medi-
cine-taking. This may reflect the fact that some clients
regained independence or semi-independence, or that some
of the sickest and frailest individuals, with intensive care
needs, were discharged to residential care or died.
The most common form of medication authorisation
used by the CNS was medicine lists provided by GPs
(usually summaries printed from GPs’ electronic patient
records). Medication administration charts were infre-
quently used, and in some cases multiple medication
authorisations were used concurrently. Reliance on GP
medicine lists, letters from GPs and specialists and multiple
medication authorisations stems from difficulty accessing
GPs to obtain and maintain medication charts in the com-
munity setting. However, use of these types of
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Table 2 Client characteristics
and medicines management
(n = 100 clients)
Variable Data
n (%) or median (IQR); range
Age, years 80 (73–87); 55–97
Gender female, n (%) 60 (60 %)
No. of current medical conditions 5 (3–7); 1–22
Type of medical conditionsa
Cancer, leukemia, lymphoma (excluding skin cancer) 32 (32 %)
Diabetes 32 (32 %)
Respiratory disease 17 (17 %)
Dementia or Alzheimer’s disease 16 (16 %)
Myocardial infarction 15 (15 %)
Cerebrovascular accident 14 (14 %)
Renal disease 11 (11 %)
Congestive heart failure 8 (8 %)
Others 8 (8 %)
Age-adjusted Charlson Comorbidity Index score 6 (5–8); 1–13
Charlson score C5 (higher risk of mortality) 77 (77 %)
Cognitive impairmentb 30 (30 %)
Number of medicinesc 10 (6–13); 2–26
Reason for referral to CNS
Medicines management ONLYd 81 (81 %)
Medicines management plus OTHER caree 19 (19 %)
Source of referral to CNS
Hospital 39 (39 %)
Family or informal carer 12 (12 %)
Palliative care service 12 (12 %)
Case manager 11 (11 %)
General practitioner 10 (10 %)
Aged Care Assessment Team 6 (6 %)
Medical specialist 3 (3 %)
Community health service 2 (2 %)
Self 1 (1 %)
Unknown 4
Duration of care (length of stay) with CNS
1–7 days 25 (25 %)
8–30 days 29 (29 %)
31–60 days 21 (21 %)
[60 days 25 (25 %)
Discharge location
Home 56 (56 %)
With self-care or informal care 41
Client terminated care 4
With other formal care 2
Ongoing care not documented 9
Acute hospital 20 (20 %)
Subacute or palliative care hospital 5 (5 %)
Residential care 9 (9 %)
Died at home 8 (8 %)
Unknown 2 (2 %)
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authorisation and multiple authorisations is associated with
risk of medication errors. It has been reported in several
studies that GP medicine lists have a high rate of errors and
discrepancies, for a variety of reasons including that the GP
is often not the only prescriber and because patient records
are not always updated when there are dose-changes and
medicines ceased [9, 24, 25]. There were 26 medication
errors related to discrepancies between medication autho-
risations and clients’ medicines (usually pharmacy-packed
dose administration aids [DAAs]), which may reflect
inaccurate medication authorisations and/or deficiencies in
interdisciplinary communication (e.g. GP or other pre-
scriber failing to notify the pharmacy of a medicine change
for a DAA client, or GP being unaware of a medicine
change initiated by another prescriber).
Multi-compartment DAAs were used by nearly 50 % of
CNS clients. Whilst these may simplify medicines man-
agement for some older people, they can also increase the
cost and complexity of medicines management and there is
evidence that they are sometimes used unnecessarily [12,
26]. In this study almost half of the clients who used a DAA
were receiving CNS visits 7 days a week, and almost one
quarter had their DAA stored in a locked box. It is likely that
some of these clients could have been managed without a
DAA since theywere not self-administering their medicines.
Medication errors were prevalent, with 41 % clients
having one or more error identified. Almost three quarters
resulted from clients (or carers) missing doses or taking
medicines incorrectly. It is not surprising that client/carer
errors were common given that CNS clients were older
people with functional and/or cognitive decline who were
referred for medicines management support, and many
continued to have some involvement in taking their
medicines (since the CNS could usually visit only once a
day and medicines often needed to be taken at other times).
However, it is also possible that healthcare providers and
their systems contributed to some of the errors attributed to
clients. For example, failure to simplify unnecessarily
complex medication regimens or to choose the simplest
dose-forms sometimes contributed to client errors. It is
common practice for CNS nurses to set out the evening
doses for clients when they visit in the morning, in order to
avoid multiple daily visits, and this practice was sometimes
associated with missed doses when the client forgot to take
those medicines.
Medication errors caused by CNS staff were uncommon,
however this is likely to be an underestimate because these
were difficult to detect using retrospective methodology
(which was largely reliant on CNS staff identifying and
documenting such errors) and with low usage of medica-
tion administration charts. In hospitals and residential care
settings, using medication chart audits and direct obser-
vation of staff administering medicines, much higher error
rates have been reported [27, 28].
Missing the occasional dose of a medicine is unlikely to
be clinically significant for most medicines, so whilst
Table 2 continued
Variable Data
n (%) or median (IQR); range





Single-compartment DAA used by CNS for setting out evening doses
when nurse visited in the morning
12 (12 %)
Locked box used by CNS to store medicines 17 (17 %)g
CNS community nursing service, DAA Dose Administration Aid
a Conditions included in the Charlson Comorbidity Index
b Likely to be an underestimate, because only 36 % clients had a MMSE or RUDAS score documented
c Number of medicines at the time of admission to RDNS (includes regular and when required medicines;
when combination products were used the individual active ingredients were counted as separate
medicines). Data not available for 15 clients
d Monitoring medicine-taking, administering medicines, medicines prompting and assisting with self-
administration
e Wound care (n = 14), personal care such as hygiene or mobility assistance (n = 7), clinical monitoring
such as blood pressure, weight, bowel function, pain, fluids (n = 7)
f 20/47 (42.6 %) clients using a multi-compartment DAA received CNS visits 7 days a week
g 11/47 (23.4 %) clients using a multi-compartment DAA had a locked box used to store the medicines
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missed doses were the most common error, many were of
minimal clinical importance. However, some errors had
potential to cause harm, such as clients double-dosing,
often due to confusion associated with the use of DAAs,
clients taking an incorrect dose (including cases involving
insulin, warfarin and prednisolone), clients potentially
receiving incorrect medicines or doses as a result of inac-
curate medicine lists, inter-professional communication
failures, prescribing errors or dispensing errors and running
out of medicines. One-third of errors involved medicines
associated with moderate or high risk of AMEs if admin-
istered incorrectly.
AMEs requiring medical attention were identified in
13 % of CNS clients, including medication-related hospital
admissions in 9 % of clients. This may be an underesti-
mate, as identification of AMEs relied on CNS documen-
tation. It is possible that some AMEs were not recognised
or documented by CNS nurses. A majority of AMEs were
considered to be potentially preventable, which is consis-
tent with studies in other populations [29, 30].
The most common cause of AMEs was prescribing
problems (Table 5). This, plus the high number of medi-
cation errors, and in particular errors related to discrepan-
cies between medication authorisations and pharmacy-
Table 3 Community nursing service (CNS) visits
First week of care (100 clients)
n (%) clients
Last week of care (71 clients)a
n (%) clients
No. of days per week that CNS visited clients
1 to 2 19 (19.0 %) 28 (39.4 %)
3 to 4 23 (23.0 %) 8 (11.2 %)
5 to 6 19 (19.0 %) 14 (19.8 %)
7 39 (39.0 %) 21 (29.6 %)
Median 5 (IQR 3–7, range 1–7) 4 (IQR 2–7, range 1–7)
No. of times CNS visited per day
1 87 (87.0 %) 64 (90.1 %)
2 9 (9.0 %) 5 (7.0 %)
3 4 (4.0 %) 2 (2.8 %)
Primary reason for CNS medicines support visits (as per care plan)
Administering medicines 44 (44 %) 27 (38.0 %)
Monitoring medicine-taking 32 (32 %)b 28 (39.4 %)
Assisting with medicine-taking 16 (16 %) 7 (9.9 %)
Prompting medicine-taking 8 (8.0 %) 6 (8.5 %)
Other – 3 (4.2 %)c
Type of medicine support provided by CNS (as per progress notes)d
Assessment of medicines management 14 (14 %) 1 (1.4 %)
Administering medicines 52 (52 %) 32 (45.1 %)
Monitoring medicine-taking 55 (55 %) 39 (54.9 %)
Assisting with medicine-taking 32 (32 %) 19 (26.8 %)
Prompting medicine-taking 16 (16 %) 12 (16.9 %)
Education about medicines management 20 (20 %) 3 (4.2 %)
Liaising with community pharmacy or doctors about clients’ medicines 8 (8 %) 1 (1.4 %)
Medicines support provided for
All prescribed medicines 50 (50 %) 40 (56.3 %)
Selected medicinese 48 (48 %) 26 (36.6 %)
Not documented 2 (2.0 %) 5 (5.0 %)
a Last week data only includes clients whose length of stay with CNS was C14 days
b Sometimes combined with education (e.g. education and monitoring for clients newly commenced on insulin)
c No longer needing medicines management support in final week of care, but still receiving other care (monitoring blood sugar level n = 1;
wound care n = 2)
d Most clients had more than one type of medicines support documented
e Some clients self-administered most of their medicines but required support with particular medicines such as injectable medicines, warfarin,
eye drops
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Table 4 Medication errors
(n = 100 clients)
Variable Data
n (%) or median (IQR); range
Clients with one or more medication error 41 (41 %)
Number of errors identified 137
No. of medication errors per client
1 14
2 10
3 or more 17
Type of medication errors
Missed dose 67 (48.9 %)
Discrepancy between medication authorisation and client’s medicines 26 (19.0 %)a
Wrong dose taken/given 13 (9.5 %)
Medicine taken from wrong compartment of DAA 12 (8.8 %)
Extra dose taken/given 15 (10.9 %)
Wrong administration method 2 (1.5 %)
Wrong route of administration 1 (0.7 %)
Wrong dose time 1 (0.7 %)






Total 22/137 (16.1 %)








Total 23 (16.8 %)
Causes of error(s)
Client/carerb 101 (73.7 %)
Healthcare provider/systemc 36 (26.3 %)
DAA dose administration aid
a In 22 cases the discrepancy involved a pharmacy-packed DAA
b Client/carer errors (e.g. forgot to take medicine, accidentally took wrong dose, dropped tablet on the
floor) or deliberate non-adherence (e.g. chose not to take a medicine or varied the dose). It was not possible
to accurately quantify what proportion were unintended errors versus deliberate non-adherence using
retrospective methodology; however, a large majority appeared to be errors
c Errors caused by general practitioners and other prescribers, pharmacists and nurses. This includes
prescribing errors, dispensing errors, administration errors and communication failures. The number of
errors attributed to each of these categories could not be accurately quantified retrospectively, because often
the specific cause could not be determined. For example, when there was a discrepancy between the
medication authorisation and the client’s medicines (n = 26), it was not possible to determine whether this
was due to an error on the authorisation, a dispensing/DAA packing error, or lack of communication
between members of the healthcare team following a medicine change. Other provider/system errors were:
medicines not available (not re-ordered or not delivered by pharmacy) (n = 3), multiple DAAs delivered
resulting in client confusion and error (n = 3), patch not removed when new one applied (n = 1), problem
with syringe driver (n = 1), delayed nurse visit (n = 1)
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Table 5 Adverse medication events (AMEs)
Patient AME Medicine(s) Underlying
cause of
AME
Causality Preventability Severity Contribution
to hospital
admission
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5 mg taken by client
inadvertently on one

























hospital on a short
course of
prednisolone
Hypoglycaemia Lantus (insulin) 22 units
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in hospital), gliclazide MR
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irbesartan 300 mg/
hydrochlorothiazide
12.5 mg daily, atenolol
50 mg daily,

























Medicines Management in Older People in a Community Nursing Service 21
packed DAAs, suggests that CNS clients could benefit
from better interdisciplinary collaboration. Interdisci-
plinary collaboration is needed to enable a ‘best possible
medication history’ and medication reconciliation [31] to
occur on admission to the CNS (in order to ensure that the
correct medicine regimen is implemented and all members
of the healthcare team have access to the same medicine
list) [6, 12], to increase the use of medication administra-
tion charts (which enable clear documentation of medica-
tion administration and improve medication safety), and to
facilitate interdisciplinary medication reviews. Despite
CNS clients’ high risk of AMEs, and eligibility for gov-
ernment-funded interdisciplinary care services, there was
little evidence of formal interdisciplinary collaboration in
relation to medicines management.
Interdisciplinary medication reviews such as HMR have
been shown to identify and address medicine discrepancies,
medication-related problems and inappropriate prescribing,
simplify medication regimens and reduce the risk of AMEs
[6, 11, 32–35]. The CNS involved in this study, like most
CNSs, does not employ its own pharmacists or medical
practitioners, so the only way for an interdisciplinary
medication review to occur is if the clients’ GP initiates an
HMR (nurses are not able to initiate government-funded
HMRs). The low use of HMR in this cohort is consistent
with previous Australian studies in high-risk groups such as
people referred to Aged Care Assessment Teams or
residing in supported accommodation [34, 36]. Efforts to
increase the uptake of HMRs, even in high-risk groups
such as CNS clients, have had limited success [34, 37],
suggesting that alternative methods to facilitate interdisci-
plinary medicines management are needed. One option is
for the CNS to employ clinical pharmacists to work with its
nurses to undertake medication reconciliation and medici-
nes reviews, and liaise with clients’ GPs and community
pharmacists. A pilot study exploring the role of clinical
pharmacists in a CNS is currently underway [38].
A limitation of our study was that it included only one
metropolitan CNS. Further studies are warranted to deter-
mine the extent to which these findings are generalisable to
other CNSs, in particular in rural and regional areas. Ret-
rospective methodology may have led to underestimation
of medicine use, medication errors, AMEs and interdisci-
plinary teamwork. A strength of the study was random
Table 5 continued
Patient AME Medicine(s) Underlying
cause of
AME
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subcut infusion (faulty




















The criteria used to determine adverse medication event causality, preventability, severity and contribution to hospital admission are provided in
Supplementary File 1
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selection of subjects to obtain a sample representative of
the older people referred for medicines support. Another
strength was review of clients’ complete CNS records,
including nursing progress notes, to extract data, which is
likely to have improved detection of errors and ADRs
compared with reliance on spontaneous voluntary reporting
by nurses.
Although there has been little previous Australian
research in the home nursing setting, research conducted
internationally suggests that many of these issues are not
unique to Australia. Studies from other countries (mainly
the USA) have reported that home nursing clients often
have multiple medicines-related risk factors (including
polypharmacy, multiple healthcare providers, poor com-
munication between providers and outdated medicine lists)
leading to medication errors and AMEs [8–10, 39–41]. No
Australian or international study has previously recruited a
similar random sample and reported the type of medicines
management support provided, so it is not possible to
compare this data with other studies.
5 Conclusion
Older people referred to a CNS for medicines management
support were a frail group of people with multiple risk-
factors for AMEs. They received intensive medicines
management support, often over a prolonged period. There
was minimal formal interdisciplinary collaboration and
infrequent medication review. Medication errors and
AMEs were common. There is a need to develop and test
strategies to improve medication safety for CNS clients.
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